全文获取类型
收费全文 | 417140篇 |
免费 | 29575篇 |
国内免费 | 5775篇 |
专业分类
耳鼻咽喉 | 5628篇 |
儿科学 | 8656篇 |
妇产科学 | 10641篇 |
基础医学 | 56907篇 |
口腔科学 | 12465篇 |
临床医学 | 35111篇 |
内科学 | 83218篇 |
皮肤病学 | 8976篇 |
神经病学 | 28678篇 |
特种医学 | 15452篇 |
外国民族医学 | 97篇 |
外科学 | 64468篇 |
综合类 | 18459篇 |
现状与发展 | 19篇 |
一般理论 | 69篇 |
预防医学 | 20965篇 |
眼科学 | 10359篇 |
药学 | 35547篇 |
50篇 | |
中国医学 | 4896篇 |
肿瘤学 | 31829篇 |
出版年
2021年 | 4158篇 |
2020年 | 3162篇 |
2019年 | 4056篇 |
2018年 | 5885篇 |
2017年 | 4874篇 |
2016年 | 4764篇 |
2015年 | 5913篇 |
2014年 | 8038篇 |
2013年 | 9794篇 |
2012年 | 13240篇 |
2011年 | 13556篇 |
2010年 | 8680篇 |
2009年 | 7963篇 |
2008年 | 11781篇 |
2007年 | 12645篇 |
2006年 | 12389篇 |
2005年 | 11297篇 |
2004年 | 10557篇 |
2003年 | 10534篇 |
2002年 | 9900篇 |
2001年 | 29581篇 |
2000年 | 29652篇 |
1999年 | 24334篇 |
1998年 | 5450篇 |
1997年 | 4517篇 |
1996年 | 3940篇 |
1995年 | 3736篇 |
1994年 | 3335篇 |
1993年 | 2990篇 |
1992年 | 16183篇 |
1991年 | 14947篇 |
1990年 | 14256篇 |
1989年 | 14037篇 |
1988年 | 12641篇 |
1987年 | 12104篇 |
1986年 | 11146篇 |
1985年 | 10353篇 |
1984年 | 6920篇 |
1983年 | 5613篇 |
1982年 | 2723篇 |
1979年 | 5486篇 |
1978年 | 3349篇 |
1977年 | 2970篇 |
1975年 | 2637篇 |
1974年 | 3071篇 |
1973年 | 2869篇 |
1972年 | 2834篇 |
1971年 | 2775篇 |
1970年 | 2511篇 |
1969年 | 2546篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
Ingigerður S. Sverrisdóttir Sigrún H. Lund Ingemar Turesson Magnus Björkholm Lynn R. Goldin Ola Landgren Sigurður Y. Kristinsson 《British journal of haematology》2019,186(1):37-44
Parental longevity is associated with an increased life expectancy; results with regard to specific diseases are conflicting. There are limited data focusing on host characteristics and their effect on survival among multiple myeloma (MM) patients and individuals with monoclonal gammopathy of undetermined significance (MGUS). Therefore, our aim was to evaluate the impact of parental longevity on survival of patients with MM and MGUS. A total of 4675 patients with MM, 6812 MGUS patients and 13 398 population-based controls for MM as well as 19 110 controls for MGUS, from 1988 to 2013, were included in the study. Longevity was defined as >90 years of age. Among MM patients, parental longevity was associated with a decreased risk of death [hazard ratio (HR) = 0·92, 95% confidence interval (CI) 0·84–0·99] and the same was true for MGUS patients (HR = 0·87, 95% CI 0·78–0·96). Having one long lived parent significantly decreased the risk of death in both groups, but was not statistically significant when both parents exceeded 90 years of age. In conclusion, parental longevity decreases the risk of death for patients with MM and MGUS which may reflect the importance of the host's genetic and environmental factors in relation to survival. 相似文献
72.
W. Gao W. Cao J. Lv C. Yu T. Wu S. Wang L. Meng D. Wang Z. Wang Z. Pang M. Yu H. Wang X. Wu Z. Dong F. Wu G. Jiang X. Wang Y. Liu J. Deng L. Lu L. Li 《Journal of internal medicine》2019,286(3):299-308
The Chinese National Twin Registry (CNTR) currently includes data from 61 566 twin pair from 11 provinces or cities in China. Of these, 31 705, 15 060 and 13 531 pairs are monozygotic, same‐sex dizygotic and opposite‐sex dizygotic pairs, respectively, determined by opposite sex or intrapair similarity. Since its establishment in 2001, the CNTR has provided an important resource for analysing genetic and environmental influences on chronic diseases especially cardiovascular diseases. Recently, the CNTR has focused on collecting biologic specimens from disease‐concordant or disease‐discordant twin pairs or from twin pairs reared apart. More than 8000 pairs of these twins have been registered, and blood samples have been collected from more than 1500 pairs. In this review, we summarize the main findings from univariate and multivariate genetic effects analyses, gene–environment interaction studies, omics studies exploring DNA methylation and metabolomic markers associated with phenotypes. There remains further scope for CNTR research and data mining. The plan for future development of the CNTR is described. The CNTR welcomes worldwide collaboration. 相似文献
73.
Inna Y. Gong Nigel S. Tan Sammy H. Ali Gerald Lebovic Muhammad Mamdani Shaun G. Goodman Dennis T. Ko Andreas Laupacis Andrew T. Yan 《The Canadian journal of cardiology》2019,35(5):653-660
Background
Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.Methods
We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.Results
In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).Conclusions
Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials. 相似文献74.
75.
76.
Waisheng Zhong Zi Xu Senli Wen Tao Xie Fang Wang Qiwei Wang Jie Chen 《Journal of oral pathology & medicine》2019,48(8):720-727
77.
Zhang Di Tang Xiaojing Gao Yuan Yu Hongjing Wen Bin Fu Lili Song Shuwei Mei Changlin 《中华肾脏病杂志》2019,35(4):288-294
Objective To screen Oxalobacter formigenes (OxF) from fresh feces of healthy adults, and study its effect on the the prevention of calcium oxalate kidney stones. Methods OxF was screened and cultured from fresh feces of healthy adults. The rat model of calcium oxalate stone was established by esophageal gavage of 0.8% of ethylene glycol. Rats were divided into a control group and four groups of rats with ethylene glycol-induced calcium oxalate kidney stones according to random number table. Three groups were treated with 106 CFU, 107 CFU, 108 CFU viable OxF every day, respectively, for 4 weeks. The blood and 24-hour urine samples were collected to detect the serum creatinine, urea nitrogen, serum and urine calcium, phosphorus, magnesium and urine oxalate every week. At the end of the 4th week, the rats were sacrificed and the kidney tissues were stained with HE and Yasue. The deposition and content of calcium oxalate crystals were observed under a light microscope. Results The bacteria strain isolated from fresh feces of healthy adults was 100% as same as the known ATCC35274 bacteria strain, which means the strain screened is OxF. Among the 5 groups, there were no significant differences in body weight, Scr, BUN, serum calcium, blood magnesium, blood phosphorus, urinary magnesium and urinary phosphorus. The 24-hour urinary calcium excretion in the model group was significantly lower than that of the control group (P<0.05). After intervention with OxF solution, the 24-hour urinary calcium excretion in the 108 CFU OxF group was significantly higher than that in the model group (P<0.05), while there was no significant difference between the other intervention groups and the model. The oxalic acid excretion of 106 CFU OxF group and 107 CFU OxF group was lower than that of the model, but the difference did not reach statistical significance (P>0.05). The 24 h oxalic acid excretion in the 108 CFU OxF group was significantly lower than that of the model at the end of first week (P<0.05), and continued to decrease for the next 3 weeks. After 4 weeks of intervention, no crystal formation was observed in the control group under the deflection microscope, but a large amount of calcium oxalate crystals were formed in the renal cortex and renal medulla. The crystals were piled up and connected to each other. Yasue staining coincided with the calcium oxalate crystal in the same part of the kidneys. Compared with the model, there was no significant change in the score of calcium oxalate crystal in the kidneys of 106 CFU OxF group and 107 CFU OxF group, while the score of calcium oxalate crystal in the kidneys of 108 CFU OxF group was significantly lower (P<0.05). Conclusions OxF are successively screened from healthy adults. Daily administration of 108 CFU OxF can safely and effectively reduce the urinary oxalic acid excretion, prevent the formation of calcium oxalate crystals and inhibit the formation of stones in kidneys of rats. 相似文献
78.
79.
80.
Carlo Ammendolia Y. Raja Rampersaud Danielle Southerst Aksa Ahmed Michael Schneider Gillian Hawker Claire Bombardier Pierre Côté 《The spine journal》2019,19(3):386-394